Veracyte Correlations

VCYT Stock

USD 31.69 0.45 1.44%

The current 90-days correlation between Veracyte and Crinetics Pharmaceuticals is 0.39 (i.e., Weak diversification). The correlation of Veracyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Veracyte Correlation With Market

Weak diversification

The correlation between Veracyte and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Moving together with Veracyte Stock

0.88	A	Agilent Technologies	Pair Corr
0.82	ME	23Andme Holding	Pair Corr
0.77	VANI	Vivani Medical Earnings Call This Week	Pair Corr
0.92	DNLI	Denali Therapeutics	Pair Corr
0.94	VCEL	Vericel Corp Ord	Pair Corr
0.65	VERA	Vera Therapeutics	Pair Corr
0.68	DRTS	Alpha Tau Medical	Pair Corr
0.75	VRDN	Viridian Therapeutics Downward Rally	Pair Corr
0.72	VRPX	Virpax Pharmaceuticals	Pair Corr
0.71	VTRS	Viatris	Pair Corr
0.67	VTYX	Ventyx Biosciences	Pair Corr

Moving against Veracyte Stock

0.79	DVAX	Dynavax Technologies	Pair Corr
0.53	VALN	Valneva SE ADR	Pair Corr
0.59	VNDA	Vanda Pharmaceuticals	Pair Corr
0.56	VRNA	Verona Pharma PLC	Pair Corr
0.51	VRTX	Vertex Pharmaceuticals	Pair Corr
0.51	EDSA	Edesa Biotech	Pair Corr
0.42	VSTM	Verastem	Pair Corr

Related Correlations Analysis

	CRNX	VRDN	CYTK	GPCR	ICVX	KURA	PTGX	MRUS	REPL	CERE
CRNX		0.75	0.58	0.76	0.0	0.8	-0.08	-0.2	-0.12	0.0	CRNX
VRDN	0.75		0.58	0.82	0.0	0.61	-0.23	-0.53	0.08	0.0	VRDN
CYTK	0.58	0.58		0.64	0.0	0.49	-0.25	-0.14	0.24	0.0	CYTK
GPCR	0.76	0.82	0.64		0.0	0.74	-0.32	-0.55	0.13	0.0	GPCR
ICVX	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	ICVX
KURA	0.8	0.61	0.49	0.74	0.0		-0.15	-0.18	0.29	0.0	KURA
PTGX	-0.08	-0.23	-0.25	-0.32	0.0	-0.15		0.56	-0.26	0.0	PTGX
MRUS	-0.2	-0.53	-0.14	-0.55	0.0	-0.18	0.56		-0.09	0.0	MRUS
REPL	-0.12	0.08	0.24	0.13	0.0	0.29	-0.26	-0.09		0.0	REPL
CERE	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		CERE
	CRNX	VRDN	CYTK	GPCR	ICVX	KURA	PTGX	MRUS	REPL	CERE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GPCR	+ 0.82	VRDN
KURA	+ 0.8	CRNX
GPCR	+ 0.76	CRNX
VRDN	+ 0.75	CRNX
KURA	+ 0.74	GPCR
GPCR	+ 0.64	CYTK

High negative correlations

MRUS	- 0.55	GPCR
MRUS	- 0.53	VRDN
PTGX	- 0.32	GPCR
REPL	- 0.26	PTGX
PTGX	- 0.25	CYTK
PTGX	- 0.23	VRDN

Risk-Adjusted Indicators

There is a big difference between Veracyte Stock performing well and Veracyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Veracyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRNX	2.71	(0.59)	0.00	(0.84)	0.00	0.00	3.78	(7.53)	21.52
VRDN	2.90	(0.16)	0.00	(0.29)	0.00	0.00	4.61	(5.22)	29.75
CYTK	2.15	(0.11)	0.00	(0.48)	0.00	0.00	4.56	(4.22)	17.67
GPCR	3.60	(0.44)	0.00	(0.35)	0.00	0.00	5.95	(10.88)	25.66
ICVX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
KURA	2.35	(0.44)	0.00	(0.57)	0.00	0.00	4.48	(5.58)	13.72
PTGX	2.79	0.42	0.23	(0.38)	2.45	(3.34)	3.48	(3.74)	50.66
MRUS	1.96	0.12	0.09	(0.51)	2.52	(2.11)	4.91	(4.03)	12.66
REPL	2.82	0.09	0.00	(0.03)	0.00	0.00	5.86	(4.75)	22.75
CERE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Veracyte Corporate Management

Robert Brainin	Executive Officer	Profile
John Leite	Chief Business	Profile
Annie McGuire	Sr Counsel	Profile
Tracy Morris	VP Communications	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC